KalVista Pharmaceuticals (KALV) Return on Capital Employed Growth (5y) (2022 - 2025)
KalVista Pharmaceuticals (KALV) Return on Capital Employed Growth (5y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,071.81 Bn | - |
| 2 | Nanobiotix | 1,925.70 Bn | 1,925.64 Bn | - |
| 3 | Akari Therapeutics | 1,062.88 Bn | 1,062.88 Bn | - |
| 4 | BeOne Medicines | 469.09 Bn | 464.29 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.09 Bn | 115.84 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.32 Bn | 61.57 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.36 Bn | 63.36 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.71 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.69 Bn | 34.68 Bn | 959.66 Mn |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -4,784.00 |
| Apr 30, 2025 | -3,998.00 |
| Oct 31, 2024 | -7,353.00 |
| Jul 31, 2024 | -4,880.00 |
| Apr 30, 2024 | -6,387.00 |
| Jan 31, 2024 | -9,593.00 |
| Oct 31, 2023 | -6,325.00 |
| Jul 31, 2023 | -1,674.00 |
| Apr 30, 2023 | -1,634.00 |
| Jan 31, 2023 | 1,647.00 |
| Oct 31, 2022 | 1,854.00 |
| Jul 31, 2022 | 2,256.00 |
| Apr 30, 2022 | 1,974.00 |